Bausch Health
BHC
#5282
Rank
ยฃ1.24 B
Marketcap
ยฃ3.32
Share price
-0.45%
Change (1 day)
-32.46%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2026 (TTM): -ยฃ2.46

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.43. In 2025 the company made an earnings per share (EPS) of ยฃ0.32 an increase over its 2024 EPS that were of -ยฃ0.09005.

EPS history for Bausch Health from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.46-880.15%
2025ยฃ0.32-450%
2024-ยฃ0.09005-92.59%
2023-ยฃ1.22160.89%
2022-ยฃ0.47-76.64%
2021-ยฃ1.9968.45%
2020-ยฃ1.18-68.91%
2019-ยฃ3.81-57.11%
2018-ยฃ8.88-272.22%
2017ยฃ5.16-199.29%
2016-ยฃ5.19798.7%
2015-ยฃ0.58-128.31%
2014ยฃ2.04-204.62%
2013-ยฃ1.95602.7%
2012-ยฃ0.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-ยฃ0.20-91.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.71-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA